As with the MESA cohort, individuals with Lp(a) levels ≥30 mg/dL had a16% reduced risk of incident AF compared with those with normal levels (adjustedHR 0.84, 95% CI 0.71–0.99; p = 0.035) [37]. This evidence concerns the gene LPA and atrial fibrillation.